Navigation Links
European Consumers Share a High Interest in Healthcare, but Hold Varied Views on Many Health Issues New TNS Healthcare Study Reveals Both Differences and Similarities in Health Views across Europe
Date:7/7/2009

NEW YORK, July 7 /PRNewswire/ -- More than 90% of consumers across the five major European markets--the UK, France, Italy, Germany and Spain-share an interest in health, according to a new study by TNS Healthcare, a Kantar Health Company. European woman are significantly more concerned with health than men, with 95% of females expressing interest in health issues vs. 89% of males. Age also makes a difference, with 55% of those older than 55 expressing an interest in health vs. just 44% of those between 18 and 24.

"The study indicates that, in all countries, most people take health for granted while they are young, particularly if they have no health issues," says Louise Tamblin, Practice Area Lead in Brand and Communications Research at TNS Healthcare UK. "Those who do suffer from any medical condition-even if it's minor-become significantly more interested in health than those who do not."

Europeans Have Many Areas of Commonality Europeans share the same views on many health issues. For example, the majority of consumers in all countries agree that they only go to the doctor when necessary. They also believe that they know when to visit a doctor vs. when to self medicate.

"Interestingly, doctors think differently about how well consumers judge whether to visit a physician or treat themselves," says Ginny Rose, Practice Area Lead in Patient Understanding, OTC and Consumer Health Research, TNS Healthcare UK. "For example, while 81% of consumers in the UK agree with the statement that they know when to go to the doctor and when to self medicate, more than 50% of doctors disagree."

Both consumers and doctors across the five countries surveyed share positive perceptions of pharmacists. There also was agreement on perceptions of OTC products, with UK respondents particularly positive about non-Rx treatments. For example, 77% of UK consumers and 85% of UK doctors believe that, for some health problems, the medicines consumers can buy are just as effective as those they would get from a doctor. In addition, 83% of UK consumers and 85% of UK doctors agree that it is important to be able to buy medicines without a prescription for minor ailments.

Findings Show Disagreement across Many Aspects of the Physician Relationship The TNS Healthcare survey reveals large differences among countries and between consumers and physicians in the same country on many aspect of the physician relationship. While 64% of consumers in the UK say that they would rather buy a medicine than visit a doctor, only 18% of that country's physicians agree. Spain comes out at the opposite end of the spectrum, with just 33% of consumers saying they would prefer to buy a medicine than visit a doctor--and only 10% of physicians agreeing. There also was broad disagreement on whether it is risky for people to treat minor ailments without seeing a doctor first. The percentage of consumers believing that it is very risky for people to self treat minor conditions ranged from 10% in the UK to 43% in Spain. On the physician side, respondents agreeing it is very risky ranged from just 4% in the UK to 49% in Italy. When asked whether they agree or disagree with the statement that doctors are too willing to prescribe treatments for minor ailments, doctors in most countries are harder on themselves than consumers are. For example, in the UK, 43% of doctors but only 26% of patients agree that doctors too often prescribe treatments for minor conditions. France and Spain show a similar pattern, with 40% of physicians but only about a quarter of consumers agreeing.

500 Physicians and 2500 Consumers Provide Insight TNS Healthcare's results are based on an on-line survey of 500 primary care physicians (100 per country) and 2,500 consumers 18 and older (500 per country) in the UK, France, Germany, Spain and Italy. The study was conducted in April 2009. About TNS Healthcare, a Kantar Health Company... TNS Healthcare, a Kantar Health company, provides market research consulting to the worldwide ethical and OTC pharmaceutical, biotech and medical device industries, as well as health-focused ad agencies, media and analysts. It offers globally consistent solutions and custom advisory services to support product introductions; brand, treatment and sales performance optimization; and physician and DTC promotional assessment. Informing decisions across the life cycle, TNS Healthcare offers action-ready insights for pre-launch landscaping, market and opportunity assessment, segmentation, positioning, message and campaign creation, pricing, forecasting, attitude and awareness measurement and post-launch tracking. It delivers information across stakeholders--including physicians, patients and consumers--to help companies anticipate and impact customers' behaviors. TNS Healthcare provides both qualitative and quantitative offerings, using traditional and on- line methodologies, combining worldwide reach with local expertise.

For more information, visit www.tnsglobal.com/healthcare.


'/>"/>
SOURCE TNS Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New impact factor of European Urology underlines journals outstanding position
2. European Prices of 170 Best-Selling Drugs Averaged 40 Percent Less Than U.S. Prices in 2008
3. Frost & Sullivan Identifies Innovative and Cost-Effective Technology as Key Competitive Factor in European Medical Device Market
4. European Medicines Agency (EMEA) Approves Cell Therapeutics, Inc.s September Meeting Request to Discuss OPAXIO(TM) Marketing Authorization Application
5. Euro RSCG Life Acquires Medicom Group to Further Strengthen Its Global and European Medical Education Offering
6. Frost & Sullivan European Gastroenterology Technology Implementation of the Year Award Bestowed on Crospon
7. Simbionix Signs Agreement With the European Association for Endoscopic Surgery
8. The European Association for the Study of the Liver renews publishing partnership with Elsevier
9. Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 Dimensional Gel Electrophoresis Market, States Frost & Sullivan
10. Prostate screening studies reviewed in European Urology July issue
11. Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... The Society ... MSW, has decided to move on from that role. , “No one in Washington ... did Phyllis Greenberger,” said SWHR Founder Florence Haseltine, MD, PhD. “We offer our deep ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... to residents of Westchester County for over 24 years, recently hosted its sixth ... members joined HOW for two remembrance ceremonies, each concluding with the release of ...
(Date:5/23/2016)... , ... May 23, 2016 , ... VitreosHealth is presenting ... 10, 2016 from 11:00 AM – 12:00 PM ET. To register, click ... start a proactive outreach program built on Big Data with a new predictive and ...
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... ... information management systems (LIMS), electronic laboratory notebook systems (ELNS) and related systems is ... manual data management consumes a significant amount of lab technician time and introduces ...
(Date:5/23/2016)... ... May 23, 2016 , ... SPH ... as Chief Medical Officer. Dr. O’Connor’s deep expertise in medicine and HIT will ... services teams who deliver best-in-class solutions and transformative technologies for provider, payer, and ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... ABU DHABI , UAE, May 23, 2016 ... the importance of Precision Medicine and the role ...     The First International ... under the distinguished patronage and presence of Sheikh ... Development. The conference focused in Precision Medicine, which helps provide ...
(Date:5/23/2016)... FRANCISCO , May 23, 2016 ... to reach USD 5.0 billion by 2022, according to ... increasing generation of medical waste coupled with the lack ... industry is expected to drive the demand for reprocessed ... these devices as compared to that of the original ...
(Date:5/22/2016)... 2016 DS Biopharma (DS) ... anti-inflammatory compound DS102 in chronic obstructive pulmonary disease ... (NASH) patients. Recent DS preclinical data ... tissue and has bronchodilatory, anti-inflammatory and anti-fibrotic properties ... Company will publish further detail on these findings ...
Breaking Medicine Technology: